🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepin...
Status
Completed
Location
Sleep Disorders Center of Alabama
Start Date
2023-07-27
Trial ID
NCT05875974
Treatments Being Tested
The rationale for the patient-centric, prospective, observational, non-inte...
Status
Completed
Location
Jazz Pharmaceuticals Clinical Site
Start Date
2021-04-09
Trial ID
NCT04803786
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy of low sodium o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT06950281
Treatments Being Tested
The main objectives of this study are to determine the treatment preference...
Status
Recruiting
Location
Stanford University
Start Date
2025-10-27
Trial ID
NCT06809803
Treatments Being Tested
A pre-post study will be conducted to assess whether treatment with LXB, nV...
Status
Enrolling By Invitation
Location
Leiden University Medical Center (LUMC)
Start Date
2025-03-27
Trial ID
NCT06421532
Treatments Being Tested
The rationale for the interventional, open-label, single-arm design of JZP2...
Status
Completed
Location
Wright Clinical Research, LLC
Start Date
2021-03-22
Trial ID
NCT04794491
Treatments Being Tested
The aim of this study is to quantify the change in blood pressure when part...
Status
Completed
Location
Science 37
Start Date
2023-06-26
Trial ID
NCT05869773
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of expande...
Status
Recruiting
Location
Santa Monica Clinical Trials
Start Date
2026-07-09
Trial ID
NCT07625280
Low sodium oxybate has been approved by the U.S. Food and Drug Administrati...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2024-02-14
Trial ID
NCT05837091
Treatments Being Tested